InterCure Ltd. reported earnings results for the full year ended December 31, 2025. For the full year, the company reported sales was ILS 270.2 million compared to ILS 238.85 million a year ago. Net loss was ILS 35.71 million compared to ILS 67.8 million a year ago.

Basic loss per share from continuing operations was ILS 0.66 compared to ILS 1.48 a year ago. Diluted loss per share from continuing operations was ILS 0.66 compared to ILS 1.48 a year ago.